Video
Dr. O’Malley on the gender disparities among NCCN-cited trials for urothelial carcinoma
Author(s):
“These findings are an internal validation that the disparities we're seeing are real,” says Padraic O’Malley, MD, MSc, FRCSC.
Video Player is loading.
In this video, Padraic O’Malley, MD, MSc, FRCSC, discusses the background and findings of the study, “Gender disparities in the clinical trials and real-world utilization of systemic therapy in the management of urothelial carcinoma,” which was presented recently at the Society of Women in Urology Annual Clinical Mentoring Conference. O’Malley is an assistant professor in the department of urology at the University of Florida in Gainesville.
Related Videos
Stephen J. Freedland, MD, on the benefits of mCRPC treatments translating to the real world
Preston Sprenkle, MD, highlights trial of TULSA vs radical prostatectomy
Sam Chang, MD, shares updated data on nogapendekin alfa inbakicept in NMIBC
Expert discusses the NMIBC trials landscape
John Gore, MD, on bladder preservation in muscle–invasive bladder cancer
Joy Maulik, CRNP, on the importance of genetic testing in prostate cancer
5 key trial insights from AUA 2025
Experts discuss expanding use of vibegron for OAB
John Michael DiBianco, MD, on silicone vs polyurethane stents for patients with kidney stones
Félix Guerrero-Ramos, MD, on TAR-200 in papillary disease-only NMIBC
Related Content
